GlassScriptPhysician profile
Morton R Rinder
NPI 1881799336
$26,578.86
in general payments reported to CMS, 2019-2025
58 companies · $5,577 in 2025
The $5,577 reported for 2025 was more than what 84% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,794 · 2020: $2,787 · 2021: $3,626 · 2022: $3,222 · 2023: $3,514 · 2024: $4,059 · 2025: $5,577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $1,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,697.47 |
| Travel and Lodging | $1,452.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,108.47 | 2019-2025 | Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Medtronic, INC. | $2,401.19 | 2021-2025 | Onyx Frontier, Corevalve Evolut R, Ffrangio |
| Novartis Pharmaceuticals Corporation | $1,845.15 | 2019-2025 | |
| Boston Scientific Corporation | $1,561.72 | 2019-2025 | Watchman Access System, Synergy, Rotablator Rotational Atherectomy System Console Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,472.08 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $1,463.30 | 2019-2024 | Xarelto |
| Abiomed | $1,134.37 | 2019-2025 | Impella |
| Pfizer INC. | $1,010.27 | 2019-2025 | |
| Amgen INC. | $980.80 | 2019-2025 | Repatha, Repatha |
| Medtronic Vascular, INC. | $860.26 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $830.67 | 2019-2025 | Jardiance |
| Amarin Pharma, INC. | $643.60 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $636.60 | 2019-2025 | Camzyos, Eliquis |
| Penumbra, INC. | $603.22 | 2019-2023 | Indigo System |
| Sanofi-Aventis U.S. LLC | $572.35 | 2019-2024 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $494.84 | 2021-2025 | Verquvo |
| Biosense Webster, INC. | $453.37 | 2019-2025 | Carto 3 |
| Abbott Laboratories | $440.53 | 2019-2024 | Diamondback Coronary, Navitor, Ensite Precision |
| Astrazeneca Pharmaceuticals LP | $420.53 | 2019-2024 | Wainua |
| Esperion Therapeutics, INC. | $338.05 | 2020-2025 | Nexletol |
| Scpharmaceuticals INC. | $329.96 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $320.92 | 2021-2025 | |
| Astellas Pharma US INC | $317.61 | 2019-2022 | |
| Chiesi USA, INC. | $301.55 | 2019-2022 | |
| Shockwave Medical, INC | $265.03 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cvrx, INC. | $244.90 | 2023-2025 | Barostim Neo System |
| Heartflow, INC. | $237.38 | 2024-2025 | |
| Cardiovascular Systems INC. | $226.15 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $202.25 | 2022-2025 | Optimizer, Optimizer |
| Kiniksa Pharmaceuticals International, Plc | $191.37 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $180.67 | 2022-2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $154.64 | 2022-2025 | Assure Wcd |
| Lundbeck LLC | $149.81 | 2019-2020 | |
| Biotronik INC. | $149.58 | 2024 | Zero Gravity |
| Novo Nordisk INC | $145.89 | 2025 | Ozempic, Rybelsus, Wegovy |
| Daiichi Sankyo INC. | $115.79 | 2019-2023 | Injectafer |
| Kowa Pharmaceuticals America, INC. | $107.07 | 2020-2021 | |
| Asahi Intecc USA, INC. | $60.53 | 2025 | Asahi Coronary Wires |
| Alnylam Pharmaceuticals INC. | $50.22 | 2021-2023 | Onpattro |
| Terumo Medical Corporation | $47.90 | 2023-2025 | Azur Cx Detachable, Angio-Seal, Metacross Otw |
| Regeneron Healthcare Solutions, INC. | $47.46 | 2019-2020 | |
| Teleflex LLC | $42.75 | 2021-2023 | Vascband |
| Actelion Pharmaceuticals US, INC. | $41.97 | 2019-2022 | |
| Bardy Diagnostics, INC. | $40.05 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $37.43 | 2019-2020 | |
| Cordis US Corp. | $35.98 | 2025 | Mynx Control Venous |
| Validus Pharmaceuticals LLC | $31.06 | 2025 | Lopressor, Raldesy |
| Itamar Medical INC | $30.55 | 2025 | Watchpatone |
| Amryt Pharma Holdings LTD | $29.97 | 2020-2021 | |
| Inari Medical, INC. | $29.64 | 2020-2021 | |
| Zoll Circulation INC | $23.66 | 2021 | |
| Philips North America LLC | $23.04 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Ge Healthcare | $19.94 | 2020 | |
| Braemar Manufacturing, LLC | $18.11 | 2019 | |
| Getinge USA Sales, LLC | $16.71 | 2023 | Cardiosave Hybrid, Type B Plug |
| Portola Pharmaceuticals, LLC | $16.65 | 2019 | |
| Angiodynamics, INC. | $11.96 | 2019 | |
| Irhythm Technologies, INC. | $11.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morton Rinder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.